FMR LLC has acquired a 2% stake in LENZ Therapeutics, signaling growing interest in the biological products sector.
| Name | LENZ Therapeutics, Inc. |
|---|---|
| CIK | 0001815776 |
| Tickers | LENZ |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 844867570 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 858-925-7000 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
FMR LLC has acquired a 2% stake in LENZ Therapeutics, signaling growing interest in the biological products sector.
BML Investment Partners, L.P. reveals a 6.7% stake in LENZ Therapeutics, indicating growing investor interest in the biological products sector.
LENZ Therapeutics has granted significant stock options to CFO Daniel Chevallard, reflecting leadership incentives amid industry developments.
LENZ Therapeutics, Inc. releases Q3 results, showcasing its growth and strategic direction in the biological products sector.
LENZ Therapeutics reports changes in beneficial ownership as per SEC filing, indicating a shift in investor stakes within the biological products sector.
LENZ Therapeutics reports significant stock sales by major stakeholders, reflecting potential shifts in ownership dynamics within the biotech sector.
Millennium Management LLC reports a 3.7% stake in LENZ Therapeutics, indicating increased investment interest in the biological products sector.
359 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002766 | 005-92660 | 261526201 | 34 | 11692 | |||
| 2026-11-04 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001373604-26-000076 | 005-92660 | 261521892 | 34 | 7163 | |||
| 2026-11-03 | 4 | FORM 4 | 0001706176-26-000007 | 6574 | ||||||
| 2026-11-03 | 10-Q | 10-Q | 0001815776-26-000059 | 001-40532 | 261517445 | 34 | 6189420 | 1 | 1 | |
| 2026-11-02 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001346824-26-000251 | 005-92660 | 261513801 | 34 | 16547 | |||
| 2026-11-02 | 4 | xslF345X06/form4-11022026_101120.xml | 0001231919-26-001526 | 15143 | ||||||
| 2026-10-28 | 8-K | 8-K | 2.02,2.05,5.02,9.01 | 0001815776-26-000056 | 001-40532 | 261496290 | 34 | 304814 | 1 | 1 |
| 2026-10-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002052113-26-001098 | 005-92660 | 261490510 | 34 | 11129 | |||
| 2026-10-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-117887 | 005-92660 | 261476828 | 34 | 15515 | |||
| 2026-09-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002292 | 005-92660 | 261363756 | 34 | 11735 | |||
| 2026-08-11 | 10-Q | 10-Q | 0001815776-26-000052 | 001-40532 | 261263339 | 34 | 6075675 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001815776-26-000051 | 001-40532 | 261263228 | 34 | 266113 | 1 | 1 |
| 2026-07-02 | 8-K | 8-K | 5.02 | 0001815776-26-000046 | 001-40532 | 261152691 | 34 | 144488 | 1 | 1 |
| 2026-06-26 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-078313 | 005-92660 | 261130167 | 34 | 15886 | |||
| 2026-06-15 | 4 | xslF345X06/form4-06162026_120622.xml | 0001231919-26-000640 | 14606 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001796789-26-000004 | 5884 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001340881-26-000001 | 5883 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001200889-26-000001 | 5880 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001297491-26-000001 | 5857 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001825009-26-000001 | 5869 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001816523-26-000005 | 6623 | ||||||
| 2026-06-12 | 8-K | 8-K | 5.07 | 0001815776-26-000041 | 001-40532 | 261086690 | 34 | 154509 | 1 | 1 |
| 2026-05-11 | 10-Q | 10-Q | 0001815776-26-000037 | 001-40532 | 26963287 | 34 | 5366158 | 1 | 1 | |
| 2026-05-11 | 8-K | 8-K | 2.02,9.01 | 0001815776-26-000035 | 001-40532 | 26963214 | 34 | 236290 | 1 | 1 |
| 2026-04-28 | ARS | ARS | 0001815776-26-000029 | 001-40532 | 26908720 | 34 | 38908108 | |||
| 2026-04-28 | DEFA14A | DEFA14A | 0001815776-26-000028 | 001-40532 | 26908683 | 34 | 334710 | |||
| 2026-04-28 | DEF 14A | DEF 14A | 0001815776-26-000026 | 001-40532 | 26908618 | 34 | 1590285 | 1 | 1 | |
| 2026-04-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-001701 | 005-92660 | 26901052 | 34 | 11175 | |||
| 2026-04-08 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001642575-26-000004 | 005-92660 | 26847754 | 34 | 22536 | |||
| 2026-03-30 | 4 | FORM 4 | 0001796789-26-000003 | 5302 | ||||||
| 2026-03-30 | 4 | FORM 4 | 0001713795-26-000004 | 5368 | ||||||
| 2026-03-30 | 4 | FORM 4 | 0001706176-26-000004 | 4908 | ||||||
| 2026-03-24 | S-8 | S-8 | 0001815776-26-000013 | 333-294569 | 26786674 | 33 | 741411 | 1 | 1 | |
| 2026-03-24 | 10-K | 10-K | 0001815776-26-000011 | 001-40532 | 26786281 | 34 | 22002383 | 1 | 1 | |
| 2026-03-24 | 8-K | 8-K | 2.02,9.01 | 0001815776-26-000008 | 001-40532 | 26784243 | 34 | 265225 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-016363 | 005-92660 | 26640756 | 34 | 10019 | |||
| 2026-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000453 | 005-92660 | 26601934 | 34 | 11834 | |||
| 2026-01-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000687 | 005-92660 | 26545865 | 34 | 11168 | |||
| 2026-01-07 | 8-K | 8-K | 2.02,9.01 | 0001815776-26-000003 | 001-40532 | 26516527 | 34 | 179152 | 1 | 1 |
| 2026-01-06 | 4 | FORM 4 | 0002015796-26-000002 | 8814 | ||||||
| 2026-01-06 | 4 | FORM 4 | 0002015900-26-000002 | 8815 | ||||||
| 2026-01-06 | 4 | FORM 4 | 0001706176-26-000002 | 8811 | ||||||
| 2026-01-06 | 4 | FORM 4 | 0001713795-26-000002 | 6068 | ||||||
| 2025-12-12 | 8-K | 8-K | 8.01 | 0001815776-25-000077 | 001-40532 | 251568261 | 34 | 146313 | 1 | 1 |
| 2025-11-19 | 4 | FORM 4 | 0002015796-25-000003 | 11422 | ||||||
| 2025-11-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-008982 | 001-40532 | 251491526 | 33 | 5226 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-112625 | 005-92660 | 251487238 | 34 | 12654 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004990 | 005-92660 | 251485676 | 34 | 16988 | |||
| 2025-11-10 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-274461 | 005-92660 | 251467074 | 34 | 25131 | |||
| 2025-11-10 | 4 | FORM 4 | 0001815776-25-000073 | 6038 | ||||||
| 2025-11-07 | 4 | FORM 4 | 0001815776-25-000072 | 6134 | ||||||
| 2025-11-07 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001346824-25-000043 | 005-92660 | 251463330 | 34 | 16965 | |||
| 2025-11-07 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002920 | 005-92660 | 251461155 | 34 | 11789 | |||
| 2025-11-05 | 10-Q | 10-Q | 0001815776-25-000071 | 001-40532 | 251454045 | 34 | 6678353 | 1 | 1 | |
| 2025-11-05 | 8-K | 8-K | 2.02,9.01 | 0001815776-25-000069 | 001-40532 | 251451918 | 34 | 240887 | 1 | 1 |
| 2025-10-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-002599 | 005-92660 | 251401850 | 34 | 11117 | |||
| 2025-10-08 | 8-K | 8-K | 8.01 | 0001815776-25-000064 | 001-40532 | 251382788 | 34 | 144011 | 1 | 1 |
| 2025-10-02 | 4 | 4 | 0001193125-25-228493 | 30564 | ||||||
| 2025-09-30 | 8-K | 8-K | 7.01,8.01,9.01 | 0001815776-25-000062 | 001-40532 | 251358203 | 34 | 181823 | 1 | 1 |
| 2025-09-22 | 4 | 4 | 0001193125-25-211363 | 29915 | ||||||
| 2025-09-22 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-211357 | 005-92660 | 251330271 | 34 | 25351 | |||
| 2025-08-26 | 4 | 4 | 0000950170-25-111529 | 41134 | ||||||
| 2025-08-20 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-25-110483 | 005-92660 | 251237706 | 34 | 24764 | |||
| 2025-08-19 | 4 | 4 | 0000950170-25-110163 | 26378 | ||||||
| 2025-07-31 | 8-K | 8-K | 8.01,9.01 | 0001815776-25-000059 | 001-40532 | 251172438 | 34 | 182205 | 1 | 1 |
| 2025-07-30 | 10-Q | 10-Q | 0001815776-25-000056 | 001-40532 | 251166920 | 34 | 6510709 | 1 | 1 | |
| 2025-07-30 | 8-K | 8-K | 2.02,9.01 | 0001815776-25-000054 | 001-40532 | 251164019 | 34 | 229749 | 1 | 1 |
| 2025-07-14 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-25-095617 | 005-92660 | 251122239 | 34 | 24266 | |||
| 2025-07-14 | 4 | 4 | 0000950170-25-095616 | 22038 | ||||||
| 2025-07-01 | 4 | 4 | 0000950170-25-092373 | 22588 | ||||||
| 2025-06-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-25-089455 | 005-92660 | 251069515 | 34 | 24331 | |||
| 2025-06-20 | 4 | 4 | 0000950170-25-088604 | 24372 | ||||||
| 2025-06-12 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-25-085511 | 005-92660 | 251043564 | 34 | 23963 | |||
| 2025-06-12 | 4 | 4 | 0000950170-25-085490 | 22035 | ||||||
| 2025-06-11 | 4 | xslF345X05/form4-06112025_110656.xml | 0001415889-25-016757 | 14213 | ||||||
| 2025-06-11 | 4 | FORM 4 | 0001815776-25-000048 | 459318 | ||||||
| 2025-06-11 | 4 | FORM 4 | 0001815776-25-000047 | 460105 | ||||||
| 2025-06-11 | 4 | FORM 4 | 0001815776-25-000046 | 459412 | ||||||
| 2025-06-11 | 4 | FORM 4 | 0001815776-25-000045 | 459270 | ||||||
| 2025-06-11 | 4 | FORM 4 | 0001815776-25-000044 | 459795 | ||||||
| 2025-06-11 | 4 | FORM 4 | 0001815776-25-000043 | 460083 | ||||||
| 2025-06-10 | 8-K | 8-K | 5.07 | 0001815776-25-000036 | 001-40532 | 251037838 | 34 | 158120 | 1 | 1 |
| 2025-05-09 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001415889-25-012499 | 005-92660 | 25930711 | 34 | 21096 | |||
| 2025-05-07 | 10-Q | 10-Q | 0001815776-25-000032 | 001-40532 | 25921613 | 34 | 5877298 | 1 | 1 | |
| 2025-05-07 | 8-K | 8-K | 2.02,9.01 | 0001815776-25-000030 | 001-40532 | 25921394 | 34 | 217840 | 1 | 1 |
| 2025-04-28 | ARS | ARS | 0001193125-25-100677 | 001-40532 | 25880998 | 34 | 2529249 | |||
| 2025-04-28 | DEFA14A | DEFA14A | 0001193125-25-100656 | 001-40532 | 25880915 | 34 | 359819 | |||
| 2025-04-28 | DEF 14A | DEF 14A | 0001193125-25-100630 | 001-40532 | 25880845 | 34 | 1239852 | 1 | 1 | |
| 2025-04-15 | 8-K | 8-K | 2.02,7.01,8.01 | 0001815776-25-000025 | 001-40532 | 25837707 | 34 | 156045 | 1 | 1 |
| 2025-04-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001108 | 333-286398 | 25837457 | 33 | 1962 | ||
| 2025-04-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001107 | 333-286397 | 25837456 | 33 | 1962 | ||
| 2025-04-14 | 424B5 | 424B5 | 0001628280-25-017695 | 333-286398 | 25836344 | 33 | 378236 | |||
| 2025-04-14 | 424B3 | 424B3 | 0001628280-25-017694 | 333-286397 | 25836341 | 33 | 320808 | |||
| 2025-04-10 | CORRESP | filename1.htm | 0001628280-25-017367 | 11004 | ||||||
| 2025-04-10 | CORRESP | filename1.htm | 0001628280-25-017365 | 10979 | ||||||
| 2025-04-10 | UPLOAD | filename1.pdf | 0000000000-25-003839 | 333-286398 | 40328 | |||||
| 2025-04-10 | UPLOAD | filename1.pdf | 0000000000-25-003837 | 333-286397 | 40328 | |||||
| 2025-04-09 | 4 | FORM 4 | 0001815776-25-000022 | 7553 | ||||||
| 2025-04-09 | 424B3 | 424B3 | 0001628280-25-017190 | 333-282036 | 25825252 | 33 | 303510 | |||
| 2025-04-09 | 424B3 | 424B3 | 0001628280-25-017187 | 333-278393 | 25825236 | 33 | 315711 | |||
| 2025-04-08 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001031 | 333-282036 | 25823464 | 33 | 1975 | ||
| 2025-04-08 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001028 | 333-278393 | 25823461 | 33 | 1975 | ||
| 2025-04-04 | 8-K | 8-K | 1.01,9.01 | 0001628280-25-016824 | 001-40532 | 25815572 | 34 | 513869 | 1 | 1 |
| 2025-04-04 | S-3 | S-3 | 0001628280-25-016822 | 333-286398 | 25815555 | 33 | 1771670 | |||
| 2025-04-04 | S-3 | S-3 | 0001628280-25-016818 | 333-286397 | 25815529 | 33 | 960878 | |||
| 2025-04-04 | POS AM | POS AM | 0001628280-25-016815 | 333-282036 | 25815520 | 33 | 391720 | |||
| 2025-04-04 | POS AM | POS AM | 0001628280-25-016813 | 333-278393 | 25815509 | 33 | 405242 | |||
| 2025-03-27 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-028784 | 005-92660 | 25779592 | 34 | 16491 | |||
| 2025-03-19 | S-8 | S-8 | 0001628280-25-013856 | 333-285926 | 25753405 | 33 | 603633 | |||
| 2025-03-19 | 10-K | 10-K | 0001815776-25-000019 | 001-40532 | 25753284 | 34 | 19165162 | 1 | 1 | |
| 2025-03-19 | 8-K | 8-K | 2.02,9.01 | 0001815776-25-000017 | 001-40532 | 25752752 | 34 | 236523 | 1 | 1 |
| 2025-03-07 | 4 | FORM 4 | 0001815776-25-000011 | 7567 | ||||||
| 2025-01-13 | 4 | FORM 4 | 0001815776-25-000009 | 435120 | ||||||
| 2025-01-13 | 4 | FORM 4 | 0001815776-25-000007 | 435042 | ||||||
| 2025-01-13 | 4 | FORM 4 | 0001815776-25-000005 | 433750 | ||||||
| 2025-01-13 | 4 | FORM 4 | 0001815776-25-000003 | 434049 | ||||||
| 2024-12-17 | 4 | FORM 4 | 0001815776-24-000074 | 7562 | ||||||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-019109 | 005-92660 | 241461370 | 34 | 86541 | |||
| 2024-11-08 | SC 13D/A | SC 13D/A | 0001193125-24-254239 | 005-92660 | 241441722 | 34 | 162326 | |||
| 2024-11-06 | 424B3 | 424B3 | 0001628280-24-045466 | 333-282036 | 241429321 | 33 | 1605168 | |||
| 2024-11-06 | 424B3 | 424B3 | 0001628280-24-045463 | 333-278393 | 241429300 | 33 | 1605215 | |||
| 2024-11-06 | 10-Q | 10-Q | 0001815776-24-000071 | 001-40532 | 241429257 | 34 | 6483928 | 1 | 1 | |
| 2024-11-06 | 8-K | 8-K | 2.02,9.01 | 0001815776-24-000069 | 001-40532 | 241429239 | 34 | 235518 | 1 | 1 |
| 2024-10-28 | 424B3 | 424B3 | 0001628280-24-043870 | 333-282036 | 241398483 | 33 | 191403 | |||
| 2024-10-28 | 424B3 | 424B3 | 0001628280-24-043869 | 333-278393 | 241398481 | 33 | 191460 | |||
| 2024-10-28 | 8-K | 8-K | 8.01,9.01 | 0001815776-24-000064 | 001-40532 | 241398461 | 34 | 197282 | 1 | 1 |
| 2024-09-19 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-09-19 16:00:00 | 9999999995-24-002902 | 333-282036 | 241311574 | 33 | 1970 | ||
| 2024-09-19 | 424B3 | 424B3 | 0001628280-24-040949 | 333-282036 | 241311127 | 33 | 9070790 | |||
| 2024-09-17 | CORRESP | filename1.htm | 0001628280-24-040600 | 10185 | ||||||
| 2024-09-13 | UPLOAD | filename1.pdf | 0000000000-24-010420 | 333-282036 | 40398 | |||||
| 2024-09-11 | S-1 | S-1 | 0001628280-24-040130 | 333-282036 | 241292700 | 33 | 24772692 | 1 | 1 | |
| 2024-08-14 | 424B3 | 424B3 | 0001628280-24-037221 | 333-278393 | 241208435 | 33 | 1489591 | |||
| 2024-08-14 | 10-Q | 10-Q | 0001815776-24-000060 | 001-40532 | 241208030 | 34 | 6235663 | 1 | 1 | |
| 2024-08-14 | 8-K | 8-K | 2.02,9.01 | 0001815776-24-000058 | 001-40532 | 241207665 | 34 | 272319 | 1 | 1 |
| 2024-08-12 | 424B3 | 424B3 | 0001628280-24-036611 | 333-278393 | 241194808 | 33 | 323194 | |||
| 2024-08-12 | 8-K | 8-K | 8.01,9.01 | 0001815776-24-000053 | 001-40532 | 241194794 | 34 | 173815 | 1 | 1 |
| 2024-07-29 | SC 13G | SC 13G | 0001104659-24-083538 | 005-92660 | 241152486 | 34 | 81672 | |||
| 2024-07-23 | 4 | FORM 4 | 0001815776-24-000051 | 433975 | ||||||
| 2024-07-15 | 424B3 | 424B3 | 0001628280-24-031841 | 333-278393 | 241115934 | 33 | 325020 | |||
| 2024-07-15 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001815776-24-000049 | 001-40532 | 241115912 | 34 | 178871 | 1 | 1 |
| 2024-05-21 | S-8 | S-8 | 0001628280-24-024451 | 333-279572 | 24966919 | 33 | 645743 | |||
| 2024-05-15 | 4 | FORM 4 | 0001815776-24-000046 | 4745 | ||||||
| 2024-05-14 | 4 | FORM 4 | 0001815776-24-000044 | 5833 | ||||||
| 2024-05-09 | 424B3 | 424B3 | 0001628280-24-022248 | 333-278393 | 24930966 | 33 | 1384990 | |||
| 2024-05-08 | 10-Q | 10-Q | 0001815776-24-000042 | 001-40532 | 24927449 | 34 | 5448529 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0001815776-24-000039 | 001-40532 | 24925861 | 34 | 257512 | 1 | 1 |
| 2024-04-11 | 424B3 | 424B3 | 0001628280-24-015671 | 333-278393 | 24836880 | 33 | 6492540 | |||
| 2024-04-10 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-04-10 16:00:00 | 9999999995-24-000927 | 333-278393 | 24837026 | 33 | 1947 | ||
| 2024-04-09 | S-1/A | S-1/A | 0001628280-24-015318 | 333-278393 | 24830732 | 33 | 22292630 | 1 | 1 | |
| 2024-04-08 | CORRESP | filename1.htm | 0001628280-24-015319 | 11011 | ||||||
| 2024-04-08 | SC 13G/A | grph13ga2.htm | 0000935836-24-000347 | 005-92660 | 24829285 | 34 | 47400 | |||
| 2024-04-03 | UPLOAD | filename1.pdf | 0000000000-24-003611 | 333-278393 | 40534 | |||||
| 2024-04-03 | 8-K | 8-K | 8.01,9.01 | 0001815776-24-000035 | 001-40532 | 24816851 | 34 | 2093201 | 1 | 1 |
| 2024-03-29 | S-1 | S-1 | 0001628280-24-013816 | 333-278393 | 24804576 | 33 | 18290631 | 1 | 1 | |
| 2024-03-28 | 3 | xslF345X02/ownership.xml | 0000902664-24-002662 | 11268 | ||||||
| 2024-03-28 | SC 13G | LENZ THERAPEUTICS, INC. | 0000902664-24-002661 | 005-92660 | 24799562 | 34 | 91176 | |||
| 2024-03-28 | SC 13D | SC 13D | 0001104659-24-040539 | 005-92660 | 24799166 | 34 | 123410 | |||
| 2024-03-25 | 4 | xslF345X05/form4-03262024_120321.xml | 0001415889-24-009077 | 29810 | ||||||
| 2024-03-25 | 3 | xslF345X02/form3-03262024_120301.xml | 0001415889-24-009075 | 10433 | ||||||
| 2024-03-25 | 4 | FORM 4 | 0001815776-24-000029 | 5834 | ||||||
| 2024-03-25 | SC 13G/A | SC 13G/A | 0001104659-24-038578 | 005-92660 | 24780704 | 34 | 112977 | |||
| 2024-03-25 | 4 | FORM 4 | 0001815776-24-000028 | 13943 | ||||||
| 2024-03-25 | 4 | FORM 4 | 0001815776-24-000027 | 11839 | ||||||
| 2024-03-25 | 4 | xslF345X05/form4-03262024_120359.xml | 0001415889-24-009073 | 6643 | ||||||
| 2024-03-25 | 4 | FORM 4 | 0001815776-24-000026 | 241918 | ||||||
| 2024-03-25 | 3 | xslF345X02/form3-03262024_120339.xml | 0001415889-24-009071 | 3343 | ||||||
| 2024-03-25 | 4 | FORM 4 | 0001815776-24-000025 | 5861 | ||||||
| 2024-03-25 | 4 | FORM 4 | 0001815776-24-000023 | 6058 | ||||||
| 2024-03-25 | 4 | FORM 4 | 0001815776-24-000022 | 14180 | ||||||
| 2024-03-25 | 4 | FORM 4 | 0001815776-24-000021 | 11349 | ||||||
| 2024-03-25 | 4 | FORM 4 | 0001815776-24-000020 | 14168 | ||||||
| 2024-03-25 | 3 | FORM 3 | 0001815776-24-000019 | 238096 | ||||||
| 2024-03-25 | 3 | FORM 3 | 0001815776-24-000018 | 238983 | ||||||
| 2024-03-25 | 3 | FORM 3 | 0001815776-24-000017 | 238482 | ||||||
| 2024-03-25 | 3 | FORM 3 | 0001815776-24-000016 | 237677 | ||||||
| 2024-03-25 | 3 | FORM 3 | 0001815776-24-000015 | 237739 | ||||||
| 2024-03-25 | 3 | FORM 3 | 0001815776-24-000014 | 237972 | ||||||
| 2024-03-25 | 3 | FORM 3 | 0001815776-24-000012 | 237767 | ||||||
| 2024-03-25 | 3 | FORM 3 | 0001815776-24-000011 | 235808 | ||||||
| 2024-03-25 | SC 13D/A | SC 13D/A | 0001193125-24-076566 | 005-92660 | 24779854 | 34 | 182537 | |||
| 2024-03-25 | SC 13G | LENZ THERAPEUTICS, INC. | 0000902664-24-002595 | 005-92660 | 24779692 | 34 | 113716 | |||
| 2024-03-25 | 4 | 4 | 0000950170-24-035951 | 22845 | ||||||
| 2024-03-25 | 3 | 3 | 0000950170-24-035939 | 9748 | ||||||
| 2024-03-22 | 8-K | 8-K | 2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,9.01 | 0001628280-24-012633 | 001-40532 | 24772814 | 34 | 3137475 | 1 | 1 |
| 2024-03-19 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-071353 | 001-40532 | 24763890 | 34 | 163840 | 1 | 1 |
| 2024-03-14 | 8-K | 8-K | 5.07,9.01 | 0001193125-24-067966 | 001-40532 | 24750808 | 34 | 179350 | 1 | 1 |
| 2024-03-08 | 425 | 425 | 0001193125-24-063796 | 001-40532 | 24735587 | 34 | 51056 | |||
| 2024-03-08 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-063785 | 001-40532 | 24735522 | 34 | 194653 | 1 | 1 |
| 2024-03-05 | 425 | 425 | 0001193125-24-058515 | 001-40532 | 24718185 | 34 | 46356 | |||
| 2024-03-05 | 8-K | 8-K | 8.01 | 0001193125-24-058513 | 001-40532 | 24718182 | 34 | 189429 | 1 | 1 |
| 2024-02-27 | 10-K | 10-K | 0000950170-24-021135 | 001-40532 | 24686798 | 34 | 11277111 | 1 | 1 | |
| 2024-02-13 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-000304 | 333-275919 | 63385 | |||||
| 2024-02-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-4,,2024-02-13 16:15:00 | 9999999995-24-000415 | 333-275919 | 24631705 | 33 | 1864 | ||
| 2024-02-13 | 424B3 | 424B3 | 0001193125-24-033857 | 333-275919 | 24626879 | 33 | 9377632 | |||
| 2024-02-09 | CORRESP | filename1.htm | 0001193125-24-030364 | 10497 | ||||||
| 2024-02-09 | CORRESP | filename1.htm | 0001193125-24-030359 | 15707 | ||||||
| 2024-02-09 | S-4/A | S-4/A | 0001193125-24-030334 | 333-275919 | 24616248 | 33 | 23817144 | 1 | 1 | |
| 2024-02-09 | UPLOAD | filename1.pdf | 0000000000-24-001600 | 333-275919 | 41738 | |||||
| 2024-02-05 | CORRESP | filename1.htm | 0001193125-24-024152 | 30393 | ||||||
| 2024-02-05 | S-4/A | S-4/A | 0001193125-24-024135 | 333-275919 | 24596567 | 33 | 24335684 | 1 | 1 | |
| 2024-02-05 | SC 13G | b125243sc13g.htm | 0001214659-24-001942 | 005-92660 | 24596474 | 34 | 96972 | |||
| 2024-02-05 | SC 13G/A | SC 13G/A | 0001193125-24-024106 | 005-92660 | 24596182 | 34 | 44841 | |||
| 2024-02-01 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-000233 | 65420 | ||||||
| 2024-02-01 | UPLOAD | filename1.pdf | 0000000000-24-001242 | 333-275919 | 51608 | |||||
| 2024-01-18 | S-4/A | S-4/A | 0001193125-24-009463 | 333-275919 | 24539930 | 33 | 24104351 | 1 | 1 | |
| 2024-01-17 | CORRESP | filename1.htm | 0001193125-24-009465 | 81648 | ||||||
| 2024-01-05 | UPLOAD | filename1.pdf | 0000000000-24-000159 | 333-275919 | 70939 | |||||
| 2023-12-26 | 425 | 425 | 0001193125-23-303062 | 001-40532 | 231513746 | 34 | 30137 | |||
| 2023-12-26 | 8-K | 8-K | 8.01 | 0001193125-23-303051 | 001-40532 | 231513695 | 34 | 164479 | 1 | 1 |
| 2023-12-06 | S-4 | S-4 | 0001193125-23-289969 | 333-275919 | 231470331 | 33 | 25137541 | 1 | 1 | |
| 2023-11-17 | SC 13D/A | SC 13D/A | 0001193125-23-279834 | 005-92660 | 231419390 | 34 | 136549 | |||
| 2023-11-15 | 425 | 425 | 0001193125-23-277999 | 001-40532 | 231411660 | 34 | 40679 | |||
| 2023-11-15 | 425 | 425 | 0001193125-23-277556 | 001-40532 | 231409098 | 34 | 11285419 | |||
| 2023-11-15 | 8-K | 8-K | 1.01,3.02,5.01,5.02,7.01,9.01 | 0001193125-23-277555 | 001-40532 | 231409094 | 34 | 11756534 | 1 | 1 |
| 2023-11-13 | 10-Q | 10-Q | 0000950170-23-062942 | 001-40532 | 231398787 | 34 | 10261344 | 1 | 1 | |
| 2023-10-30 | 8-K | 8-K | 1.01,9.01 | 0000950170-23-056341 | 001-40532 | 231360284 | 34 | 793117 | 1 | 1 |
| 2023-09-13 | 8-K/A | 8-K/A | 5.02 | 0000950170-23-047925 | 001-40532 | 231252754 | 34 | 176287 | 1 | 1 |
| 2023-08-23 | 8-K | 8-K | 2.05,5.02,8.01 | 0000950170-23-044135 | 001-40532 | 231197632 | 34 | 190431 | 1 | 1 |
| 2023-08-14 | 10-Q | 10-Q | 0000950170-23-042525 | 001-40532 | 231171792 | 34 | 10376427 | 1 | 1 | |
| 2023-08-02 | 8-K | 8-K | 5.02 | 0000950170-23-037141 | 001-40532 | 231135544 | 34 | 173853 | 1 | 1 |
| 2023-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-044075 | 5570 | ||||||
| 2023-08-01 | 3 | FORM 3 SUBMISSION | 0001209191-23-044074 | 7395 | ||||||
| 2023-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-043145 | 5615 | ||||||
| 2023-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-043142 | 5602 | ||||||
| 2023-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-043140 | 5572 | ||||||
| 2023-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-043137 | 5568 | ||||||
| 2023-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-043134 | 5700 | ||||||
| 2023-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-043131 | 5763 | ||||||
| 2023-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-043129 | 5600 | ||||||
| 2023-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-043125 | 5591 | ||||||
| 2023-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-043123 | 5543 | ||||||
| 2023-07-20 | 8-K | 8-K | 5.07 | 0000950170-23-033594 | 001-40532 | 231098119 | 34 | 182755 | 1 | 1 |
| 2023-06-23 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-23-029499 | 001-40532 | 231034858 | 34 | 206352 | 1 | 1 |
| 2023-06-06 | ARS | ARS | 0000950170-23-026628 | 001-40532 | 23996275 | 34 | 3217762 | |||
| 2023-06-06 | DEFA14A | DEFA14A | 0000950170-23-026627 | 001-40532 | 23996192 | 34 | 224762 | |||
| 2023-06-06 | DEF 14A | DEF 14A | 0000950170-23-026624 | 001-40532 | 23996103 | 34 | 1046947 | |||
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021242 | 001-40532 | 23911136 | 34 | 9191854 | 1 | 1 | |
| 2023-04-27 | 10-K/A | 10-K/A | 0000950170-23-015258 | 001-40532 | 23856813 | 34 | 3634022 | 1 | 1 | |
| 2023-03-20 | S-8 | S-8 | 0000950170-23-008770 | 333-270694 | 23746591 | 33 | 203723 | |||
| 2023-03-20 | 10-K | 10-K | 0000950170-23-008764 | 001-40532 | 23746493 | 34 | 18905908 | 1 | 1 | |
| 2023-03-20 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-008761 | 001-40532 | 23746442 | 34 | 549878 | 1 | 1 |
| 2023-03-16 | 8-K | 8-K | 5.02,9.01 | 0000950170-23-008443 | 001-40532 | 23738761 | 34 | 253218 | 1 | 1 |
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-012264 | 5602 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-012259 | 5632 | ||||||
| 2023-02-22 | 8-K | 8-K | 2.05,5.02,8.01,9.01 | 0000950170-23-003808 | 001-40532 | 23654273 | 34 | 222924 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021936 | 005-92660 | 23631351 | 34 | 113276 | |||
| 2023-01-09 | SC 13G/A | grph13ga.htm | 0000935836-23-000016 | 005-92660 | 23518414 | 34 | 47168 | |||
| 2023-01-06 | 3 | FORM 3 | 0001567619-23-000700 | 5255 | ||||||
| 2023-01-05 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-000228 | 001-40532 | 23511302 | 34 | 212403 | 1 | 1 |
| 2022-12-12 | SC 13G/A | filing.txt | 0000315066-22-001882 | 005-92660 | 221456270 | 34 | 8061 | |||
| 2022-12-12 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-026333 | 001-40532 | 221456078 | 34 | 203969 | 1 | 1 |
| 2022-11-18 | SC 13G | graphitebio13g.htm | 0000935836-22-000620 | 005-92660 | 221401397 | 34 | 47178 | |||
| 2022-11-09 | 10-Q | 10-Q | 0000950170-22-023869 | 001-40532 | 221372783 | 34 | 11496715 | 1 | 1 | |
| 2022-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023837 | 001-40532 | 221372593 | 34 | 574962 | 1 | 1 |
| 2022-11-03 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-021600 | 001-40532 | 221356462 | 34 | 208075 | 1 | 1 |
| 2022-08-11 | 10-Q | 10-Q | 0000950170-22-016869 | 001-40532 | 221155894 | 34 | 10437207 | 1 | 1 | |
| 2022-08-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016857 | 001-40532 | 221155733 | 34 | 542019 | 1 | 1 |
| 2022-08-11 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-016657 | 001-40532 | 221153751 | 34 | 212897 | 1 | 1 |
| 2022-07-28 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-07-28 16:00:00 | 9999999995-22-002198 | 333-266262 | 221117110 | 33 | 1814 | ||
| 2022-07-26 | UPLOAD | filename1.pdf | 0000000000-22-007822 | 40259 | ||||||
| 2022-07-26 | CORRESP | filename1.htm | 0001193125-22-201400 | 6587 | ||||||
| 2022-07-21 | S-3 | S-3 | 0001193125-22-199216 | 333-266262 | 221097510 | 33 | 1463645 | |||
| 2022-07-13 | 8-K/A | 8-K/A | 8.01,9.01 | 0001193125-22-192923 | 001-40532 | 221081346 | 34 | 184335 | 1 | 1 |
| 2022-06-23 | 8-K | 8-K | 5.07 | 0001193125-22-180184 | 001-40532 | 221035816 | 34 | 158480 | 1 | 1 |
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038736 | 9999 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038735 | 9986 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038734 | 9954 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038733 | 9950 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038732 | 10076 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038730 | 10143 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038729 | 9982 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038727 | 9967 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038725 | 9921 | ||||||
| 2022-05-16 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-020233 | 001-40532 | 22925169 | 34 | 197586 | 1 | 1 |
| 2022-05-12 | 10-Q | 10-Q | 0001564590-22-019862 | 001-40532 | 22917933 | 34 | 8773320 | 1 | 1 | |
| 2022-05-12 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-019849 | 001-40532 | 22917772 | 34 | 448685 | 1 | 1 |
| 2022-04-29 | DEFA14A | DEFA14A | 0001193125-22-133632 | 001-40532 | 22875328 | 34 | 904801 | |||
| 2022-04-29 | DEF 14A | DEF 14A | 0001193125-22-133540 | 001-40532 | 22875114 | 34 | 1220453 | |||
| 2022-04-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-024364 | 10927 | ||||||
| 2022-04-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-024362 | 4860 | ||||||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-023268 | 5663 | ||||||
| 2022-04-05 | 3 | FORM 3 SUBMISSION | 0001209191-22-023259 | 7497 | ||||||
| 2022-03-21 | S-8 | REGISTRATION STATEMENT ON FORM S-8 | 0001193125-22-080574 | 333-263747 | 22755987 | 33 | 80109 | |||
| 2022-03-21 | 10-K | 10-K | 0001564590-22-011123 | 001-40532 | 22754282 | 34 | 18086116 | 1 | 1 | |
| 2022-03-21 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-011122 | 001-40532 | 22754272 | 34 | 561458 | 1 | 1 |
| 2022-03-02 | 8-K | 8-K | 5.02,9.01 | 0001564590-22-008273 | 001-40532 | 22703407 | 34 | 198364 | 1 | 1 |
| 2022-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-011470 | 10062 | ||||||
| 2022-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-011465 | 9961 | ||||||
| 2022-02-14 | SC 13G | SC 13G | 0001193125-22-041787 | 005-92660 | 22632381 | 34 | 43110 | |||
| 2022-02-14 | SC 13G/A | SC 13G | 0001104659-22-021026 | 005-92660 | 22624483 | 34 | 112838 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-001031 | 005-92660 | 22604353 | 34 | 8566 | |||
| 2022-01-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-004735 | 10882 | ||||||
| 2022-01-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-004346 | 10881 | ||||||
| 2021-12-20 | 8-K | 8-K | 1.01,2.03,9.01 | 0001564590-21-060737 | 001-40532 | 211505330 | 34 | 3328571 | 1 | 1 |
| 2021-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-070500 | 8672 | ||||||
| 2021-12-08 | 8-K | DEPARTURE OF DIRECTOR OR CERTAIN OFFICER | 5.02 | 0001564590-21-059679 | 001-40532 | 211477564 | 34 | 197541 | 1 | 1 |
| 2021-11-24 | 4 | FORM 4 SUBMISSION | 0001209191-21-066742 | 8665 | ||||||
| 2021-11-17 | 8-K | 8-K | 7.01,8.01,9.01 | 0001564590-21-057384 | 001-40532 | 211418631 | 34 | 197102 | 1 | 1 |
| 2021-11-16 | 8-K | 8-K | 1.01,2.03,9.01 | 0001564590-21-057277 | 001-40532 | 211415981 | 34 | 1120686 | 1 | 1 |
| 2021-11-10 | 10-Q | 10-Q | 0001564590-21-056184 | 001-40532 | 211396671 | 34 | 10833351 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K - Q3 | 2.02,9.01 | 0001564590-21-056172 | 001-40532 | 211396492 | 34 | 562611 | 1 | 1 |
| 2021-10-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-060627 | 12556 | ||||||
| 2021-10-12 | SC 13G | filing.txt | 0000315066-21-001804 | 005-92660 | 211317251 | 34 | 8575 | |||
| 2021-10-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-060060 | 13079 | ||||||
| 2021-08-12 | 10-Q | 10-Q | 0001564590-21-043980 | 001-40532 | 211167707 | 34 | 10059111 | 1 | 1 | |
| 2021-08-12 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-043954 | 001-40532 | 211167498 | 34 | 496939 | 1 | 1 |
| 2021-07-09 | SC 13D | SC 13D | 0001193125-21-211911 | 005-92660 | 211083254 | 34 | 140162 | |||
| 2021-07-09 | SC 13G | SC 13G | 0001104659-21-090669 | 005-92660 | 211083158 | 34 | 111492 | |||
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-027018 | 23718 | ||||||
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-027015 | 18505 | ||||||
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-027017 | 15115 | ||||||
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-027014 | 8685 | ||||||
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-027016 | 26530 | ||||||
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-027013 | 19451 | ||||||
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-027012 | 15437 | ||||||
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-027011 | 22546 | ||||||
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-044507 | 23178 | ||||||
| 2021-06-30 | 8-K | 8-K | 1.01,5.03,9.01 | 0001193125-21-204869 | 001-40532 | 211062781 | 34 | 346349 | ||
| 2021-06-28 | 4 | FORM 4 SUBMISSION | 0000899243-21-026342 | 5724 | ||||||
| 2021-06-28 | 4 | FORM 4 SUBMISSION | 0000899243-21-026340 | 12839 | ||||||
| 2021-06-28 | 4 | FORM 4 SUBMISSION | 0000899243-21-026339 | 5561 | ||||||
| 2021-06-28 | S-8 | S-8 | 0001193125-21-202189 | 333-257486 | 211054626 | 33 | 81872 | |||
| 2021-06-28 | 424B4 | 424B4 | 0001193125-21-200751 | 333-256838 | 211049667 | 33 | 5887666 | |||
| 2021-06-24 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-06-24 16:00:00 | 9999999995-21-002503 | 333-256838 | 211044583 | 33 | 1826 | ||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025857 | 16964 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025853 | 9279 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025851 | 11125 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025850 | 13174 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025848 | 11260 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025847 | 7989 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025842 | 11161 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025841 | 7828 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025840 | 8454 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025839 | 12529 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025837 | 12764 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025835 | 9312 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-025834 | 9234 | ||||||
| 2021-06-24 | 3 | FORM 3 SUBMISSION | 0001209191-21-043152 | 11191 | ||||||
| 2021-06-24 | S-1MEF | S-1MEF | 0001193125-21-198924 | 333-257370 | 211044122 | 33 | 48839 | |||
| 2021-06-24 | CERT | 8A_Cert_GRPH.pdf | 0001354457-21-000707 | 001-40532 | 211043247 | 34 | 238327 | |||
| 2021-06-24 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-003625 | 271992 | ||||||
| 2021-06-22 | 8-A12B | 8-A12B | 0001193125-21-196381 | 001-40532 | 211036366 | 34 | 13670 | |||
| 2021-06-22 | CORRESP | filename1.htm | 0001193125-21-196376 | 11453 | ||||||
| 2021-06-22 | CORRESP | filename1.htm | 0001193125-21-196371 | 9189 | ||||||
| 2021-06-22 | CORRESP | filename1.htm | 0001193125-21-196306 | 19248 | ||||||
| 2021-06-22 | S-1/A | S-1/A | 0001193125-21-196288 | 333-256838 | 211035840 | 33 | 5982444 | |||
| 2021-06-22 | UPLOAD | filename1.pdf | 0000000000-21-007642 | 43731 | ||||||
| 2021-06-21 | S-1/A | S-1/A | 0001193125-21-194083 | 333-256838 | 211027265 | 33 | 7457561 | |||
| 2021-06-15 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-003437 | 272999 | ||||||
| 2021-06-11 | CORRESP | filename1.htm | 0001193125-21-189013 | 19792 | ||||||
| 2021-06-11 | S-1/A | S-1/A | 0001193125-21-189004 | 333-256838 | 211012248 | 33 | 6391476 | |||
| 2021-06-10 | CORRESP | filename1.htm | 0001193125-21-188081 | 88956 | ||||||
| 2021-06-07 | UPLOAD | filename1.pdf | 0000000000-21-007021 | 45988 | ||||||
| 2021-06-04 | S-1 | S-1 | 0001193125-21-183167 | 333-256838 | 21997555 | 33 | 8887170 | |||
| 2021-05-21 | DRSLTR | filename1.htm | 0000950123-21-007275 | 56960 | ||||||
| 2021-05-21 | DRS/A | filename1.htm | 0000950123-21-007270 | 377-04677 | 21950287 | 33 | 8725582 | |||
| 2021-05-14 | UPLOAD | filename1.pdf | 0000000000-21-006170 | 62902 | ||||||
| 2021-04-16 | DRS | filename1.htm | 0000950123-21-004654 | 377-04677 | 21832475 | 33 | 5186230 | |||
| 2021-03-19 | D | xslFormDX01/primary_doc.xml | 06b | 0001815776-21-000002 | 021-392907 | 21757773 | 33 | 13660 |
One latest value per concept from companyfacts (263 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 31.42M | 2026-10-28 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 690.10M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 5.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 913,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 486,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 1.53M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | AccruedInsuranceCurrent | Accrued Insurance, Current | USD | 777,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001815776-24-000042 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 12.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.03M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 355,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 524.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 4.13M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 1.92M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 36.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 12.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 5.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | Assets | Assets | USD | 209.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 206.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AssetsHeldForSaleLongLivedFairValueDisclosure | Assets Held-for-sale, Long Lived, Fair Value Disclosure | USD | 20,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-062942 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroup | Assets Held-for-sale, Not Part of Disposal Group | USD | 2.70M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0000950170-23-042525 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 236.87M | 2022-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost | USD | 123.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value | USD | 123.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost | USD | 44.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value | USD | 43.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 176.06M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001815776-24-000071 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 176.06M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001815776-24-000071 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001815776-26-000052 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 30.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 29.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 197.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 25.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 30.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 5.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 6.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 31.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 31.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -105.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear | Contractual Obligation, to be Paid, Remainder of Fiscal Year | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-062942 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 785,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001815776-26-000052 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-20 | 0000950170-23-008764 |
| us-gaap | ConvertiblePreferredStockConvertedToOtherSecurities | Convertible Preferred Stock Converted to Other Securities | USD | 260.50M | 2021-06-28 | 2022 | FY | 10-K | 2023-03-20 | 0000950170-23-008764 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 1.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 122.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 500,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 502,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 2,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss | Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss | USD | 1.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss | DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss | USD | 175.54M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001815776-24-000071 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss | USD | 167.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 15.30M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-20 | 0000950170-23-008764 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 51.00M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-062942 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterest | DebtSecuritiesAvailableForSaleExcludingAccruedInterest | USD | 166.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | USD | 166.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 166.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | position | 95 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-19 | 0001815776-25-000019 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 488,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0001564590-22-011123 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 70.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 488,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 38.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 2.96M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 6.16M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness | Deferred Tax Assets, Tax Credit Carryforwards, General Business | USD | 7.20M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 8.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 2.02M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 295,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 70.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs | USD | 90.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 73,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 488,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | DefinedBenefitPlanSpecialTerminationBenefits | Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits | USD | 1.00M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 800,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 21,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001815776-24-000042 | |
| us-gaap | Depreciation | Depreciation | USD | 2.40M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 2.41M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 330,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -3.33 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.48 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019862 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -3.33 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.196 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.016 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.009 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 5.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 35.80M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023869 | |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueAmount | Equity Securities without Readily Determinable Fair Value, Amount | USD | 1.10M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | -71,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -71,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 40.97M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 253,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -104.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 502,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 2,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 16.03M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -17.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 282,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -71,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 263,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 114,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 763,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 1.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 584,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -4.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | IncreaseDecreaseInAssetsHeldForSale | Increase (Decrease) in Assets Held-for-sale | USD | 20,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-062942 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 785,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001815776-26-000052 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | -2.27M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 1.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -54,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -21,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -1.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | InsuranceRecoveries | Insurance Recoveries | USD | 300,000 | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001815776-26-000052 |
| us-gaap | InterestExpenseRelatedParty | Interest Expense, Related Party | USD | 40,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0001564590-22-011123 |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 1.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 4.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | InventoryNoncurrent | Inventory, Noncurrent | USD | 610,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 3.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 556,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 6.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.078 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 480,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 361,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 361,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001815776-24-000071 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 361,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001815776-25-000071 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 362,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001815776-26-000037 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 119,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 20,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | Liabilities | Liabilities | USD | 17.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 209.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 17.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 409,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 99.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -94.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -104.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | NoncashMergerRelatedCosts | Noncash Merger Related Costs | USD | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-07-30 | 0001815776-25-000056 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 6.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 70.17M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001815776-25-000071 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -111.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 7.30M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 400,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 460,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 460,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 44.12M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 421,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 559,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | OtherAssetImpairmentCharges | Other Asset Impairment Charges | USD | 56.62M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -1.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | OtherLiabilities | Other Liabilities | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-062942 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-19 | 0001815776-25-000019 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -46,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 1.38M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-19 | 0001815776-25-000019 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 32.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 28.13M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 34,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 780,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-20 | 0000950170-23-008764 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-07 | 0001815776-25-000032 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-19 | 0001815776-25-000019 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-20 | 0000950170-23-008764 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 132.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 5.00M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0001564590-22-011123 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 263.43M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | ProceedsFromSaleOfOtherPropertyPlantAndEquipment | Proceeds from Sale of Other Property, Plant, and Equipment | USD | 1.90M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 14,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 395,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -124.65M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 1.54M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 640,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 100,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | RestrictedCashEquivalents | Restricted Cash Equivalents | USD | 1.60M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 114,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 62.08M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | RestructuringCostsAndAssetImpairmentCharges | Restructuring Costs and Asset Impairment Charges | USD | 6.80M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-062942 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -331.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 10.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 17.50M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001815776-25-000071 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 53.50M | 2024-03-21 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 15.41M | 2024-03-21 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | SaleOfStockPercentageOfOwnershipAfterTransaction | Sale of Stock, Percentage of Ownership after Transaction | pure | 0.56 | 2024-03-21 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 19 | 2024-07-17 | 2024 | FY | 10-K | 2025-03-19 | 0001815776-25-000019 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 120.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | -6.57M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 12.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 0 | 2022-01-01 | 2022-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0000950170-23-042525 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | shares | 564,000 | 2023-01-01 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 4.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 5.89M | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023869 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.56 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 12.00M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023869 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 1 | 2020-06-30 | 2022 | FY | 10-K | 2023-03-20 | 0000950170-23-008764 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 192.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 8.67M | 2024-03-21 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 55,047 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0000950170-23-042525 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 143.39M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 395,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 26.07M | 2025-04-01 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 14,000 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | Supplies | Prepaid Supplies | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 | |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-19 | 0001815776-25-000019 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0.001 | 2024-03-20 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 53.76M | 2024-03-20 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 10.00M | 2020-06-30 | 2022 | FY | 10-K | 2023-03-20 | 0000950170-23-008764 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 1.05M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 4.42M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 146,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 42,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 3.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 17.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001815776-26-000011 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 2.20M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 7.27M | 2020-03-01 | 2020-03-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 31.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 54.01M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019862 |
| us-gaap | WeightedAverageNumberOfSharesIssuedBasic | Weighted Average Number of Shares Issued, Basic | shares | 58.05M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021135 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 31.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001815776-26-000059 |